Back to LBRX
JPMORGAN CHASE & CO LBRX Position History
LB Pharmaceuticals Inc • Healthcare
Quarters held
20
Latest value
$24.1M
Q3 2026
Peak value
$35.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $13.9M |
| Q3 2025 | $372K |
| Q3 2025 | $2.1M |
| Q3 2025 | $13.9M |
| Q3 2025 | $372K |
| Q3 2025 | $2.1M |
| Q4 2025 | $30M |
| Q4 2025 | $1M |
| Q4 2025 | $4.9M |
| Q1 2026 | $27M |
| Q1 2026 | $827K |
| Q1 2026 | $5.3M |
| Q2 2026 | $35.9M |
| Q2 2026 | $1.1M |
| Q2 2026 | $11.9M |
| Q3 2026 | $2.1M |
| Q3 2026 | $26.6M |
| Q3 2026 | $1M |
| Q3 2026 | $15K |
| Q3 2026 | $24.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $24.1M | 645.6K | — | — |
| Q3 2026 | $15K | 403 | — | — |
| Q3 2026 | $1M | 28.0K | — | — |
| Q3 2026 | $26.6M | 714.6K | — | — |
| Q3 2026 | $2.1M | 55.7K | — | — |
| Q2 2026 | $11.9M | 363.4K | — | — |
| Q2 2026 | $1.1M | 34.5K | — | — |
| Q2 2026 | $35.9M | 1.10M | — | — |
| Q1 2026 | $5.3M | 229.4K | — | — |
| Q1 2026 | $827K | 35.6K | — | — |
| Q1 2026 | $27M | 1.16M | — | — |
| Q4 2025 | $4.9M | 218.1K | — | — |
| Q4 2025 | $1M | 46.9K | — | — |
| Q4 2025 | $30M | 1.35M | — | — |
| Q3 2025 | $2.1M | 131.1K | — | — |
| Q3 2025 | $372K | 23.6K | — | — |
| Q3 2025 | $13.9M | 877.9K | — | — |
| Q3 2025 | $2.1M | 131.1K | — | — |
| Q3 2025 | $372K | 23.6K | — | — |
| Q3 2025 | $13.9M | 877.9K | — | — |
Other funds holding LBRX
$128.7M
$108.8M
$82.7M
$74.6M
$53.9M